Creative Planning’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$402K Sell
6,127
-202
-3% -$13.2K ﹤0.01% 2644
2025
Q1
$447K Sell
6,329
-7,593
-55% -$536K ﹤0.01% 2375
2024
Q4
$915K Buy
13,922
+7,277
+110% +$478K ﹤0.01% 1703
2024
Q3
$469K Buy
6,645
+86
+1% +$6.07K ﹤0.01% 2164
2024
Q2
$435K Buy
6,559
+131
+2% +$8.69K ﹤0.01% 2044
2024
Q1
$436K Buy
6,428
+674
+12% +$45.8K ﹤0.01% 1944
2023
Q4
$356K Buy
5,754
+396
+7% +$24.5K ﹤0.01% 1962
2023
Q3
$316K Sell
5,358
-591
-10% -$34.9K ﹤0.01% 1887
2023
Q2
$355K Sell
5,949
-198
-3% -$11.8K ﹤0.01% 1771
2023
Q1
$359K Buy
6,147
+678
+12% +$39.6K ﹤0.01% 1678
2022
Q4
$339K Sell
5,469
-39
-0.7% -$2.42K ﹤0.01% 1639
2022
Q3
$311K Hold
5,508
﹤0.01% 1617
2022
Q2
$352K Buy
5,508
+231
+4% +$14.8K ﹤0.01% 1502
2022
Q1
$342K Buy
5,277
+1,983
+60% +$129K ﹤0.01% 1542
2021
Q4
$219K Buy
3,294
+3
+0.1% +$199 ﹤0.01% 1816
2021
Q3
$201K Buy
+3,291
New +$201K ﹤0.01% 1859
2021
Q2
Sell
-5,982
Closed -$354K 2156
2021
Q1
$354K Sell
5,982
-282
-5% -$16.7K ﹤0.01% 1656
2020
Q4
$375K Buy
6,264
+351
+6% +$21K ﹤0.01% 1452
2020
Q3
$322K Buy
5,913
+585
+11% +$31.9K ﹤0.01% 1357
2020
Q2
$273K Buy
5,328
+345
+7% +$17.7K ﹤0.01% 1351
2020
Q1
$223K Sell
4,983
-585
-11% -$26.2K ﹤0.01% 1328
2019
Q4
$297K Buy
5,568
+609
+12% +$32.5K ﹤0.01% 1399
2019
Q3
$231K Sell
4,959
-285
-5% -$13.3K ﹤0.01% 1502
2019
Q2
$264K Buy
5,244
+12
+0.2% +$604 ﹤0.01% 1443
2019
Q1
$269K Sell
5,232
-102
-2% -$5.24K ﹤0.01% 1382
2018
Q4
$250K Buy
5,334
+15
+0.3% +$703 ﹤0.01% 1336
2018
Q3
$298K Buy
5,319
+306
+6% +$17.1K ﹤0.01% 1389
2018
Q2
$253K Sell
5,013
-516
-9% -$26K ﹤0.01% 1457
2018
Q1
$272K Sell
5,529
-1,224
-18% -$60.2K ﹤0.01% 1390
2017
Q4
$347K Buy
6,753
+72
+1% +$3.7K ﹤0.01% 1269
2017
Q3
$348K Sell
6,681
-57
-0.8% -$2.97K ﹤0.01% 1232
2017
Q2
$348K Buy
6,738
+72
+1% +$3.72K ﹤0.01% 1191
2017
Q1
$335K Buy
6,666
+840
+14% +$42.2K ﹤0.01% 1192
2016
Q4
$275K Sell
5,826
-906
-13% -$42.8K ﹤0.01% 1225
2016
Q3
$335K Buy
6,732
+456
+7% +$22.7K ﹤0.01% 1120
2016
Q2
$302K Sell
6,276
-1,347
-18% -$64.8K ﹤0.01% 1038
2016
Q1
$348K Sell
7,623
-1,710
-18% -$78.1K ﹤0.01% 911
2015
Q4
$503K Buy
9,333
+885
+10% +$47.7K ﹤0.01% 749
2015
Q3
$417K Buy
+8,448
New +$417K ﹤0.01% 804
2015
Q2
Sell
-7,530
Closed -$433K 1905
2015
Q1
$433K Sell
7,530
-57
-0.8% -$3.28K ﹤0.01% 800
2014
Q4
$383K Buy
7,587
+2,658
+54% +$134K ﹤0.01% 805
2014
Q3
$231K Buy
4,929
+312
+7% +$14.6K ﹤0.01% 984
2014
Q2
$208K Buy
4,617
+2,073
+81% +$93.4K ﹤0.01% 1007
2014
Q1
$107K Buy
2,544
+273
+12% +$11.5K ﹤0.01% 1362
2013
Q4
$89K Buy
2,271
+6
+0.3% +$235 ﹤0.01% 1265
2013
Q3
$80K Sell
2,265
-126
-5% -$4.45K ﹤0.01% 1253
2013
Q2
$79K Buy
+2,391
New +$79K ﹤0.01% 1115